Adam Hilterbrand
About Adam Hilterbrand
Adam Hilterbrand is a scientist specializing in gene therapy research, currently employed at Sana Biotechnology, Inc. in Cambridge, Massachusetts. He holds a Ph.D. in Microbiology and Virology from The University of Texas at Austin and has extensive research experience from institutions such as Loyola University Chicago and Tufts University School of Medicine.
Work at Sana Biotechnology
Adam Hilterbrand has been employed at Sana Biotechnology, Inc. since 2021, where he serves as a Scientist in Gene Therapy Research. His role involves advancing research initiatives focused on gene therapy, contributing to the development of innovative therapeutic solutions. Sana Biotechnology is located in Cambridge, Massachusetts, and is known for its commitment to transforming the treatment of diseases through genetic engineering.
Education and Expertise
Adam Hilterbrand earned a Bachelor of Science degree in Molecular Biology from Loyola University Chicago, where he studied from 2007 to 2011. He furthered his education at The University of Texas at Austin, obtaining a Doctor of Philosophy (Ph.D.) in Microbiology and Virology from 2011 to 2017. His academic background provides a strong foundation for his research in gene therapy.
Background
Adam Hilterbrand began his research career as an Undergraduate Research Assistant at Loyola University Chicago from 2009 to 2011. Following this, he worked as a Graduate Research Assistant at The University of Texas at Austin from 2011 to 2017. He then transitioned to a Postdoctoral Researcher position at Tufts University School of Medicine, where he worked from 2017 to 2021. His diverse experience in various research environments has shaped his expertise in gene therapy.
Research Experience
Throughout his career, Adam Hilterbrand has accumulated significant research experience in the field of gene therapy. His positions at Loyola University Chicago, The University of Texas at Austin, and Tufts University School of Medicine have allowed him to develop a comprehensive understanding of microbiology and virology. This experience has been instrumental in his current role at Sana Biotechnology.